Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome
Publication Type:Journal Article
Source:Biochimica et Biophysica Acta - Proteins and Proteomics, Volume 1834, Number 11, p.2308-2316 (2013)
Keywords:article, biological marker, cancer cell, cancer cell culture, controlled study, gene overexpression, head and neck squamous cell carcinoma, human, human cell, mass spectrometry, methodology, priority journal, protein secretion, proteomics, scatter factor, somatomedin binding protein 3, tissue microarray
Protein biomarker discovery for early detection of head and neck squamous cell carcinoma (HNSCC) is a crucial unmet need to improve patient outcomes. Mass spectrometry-based proteomics has emerged as a promising tool for identification of biomarkers in different cancer types. Proteins secreted from cancer cells can serve as potential biomarkers for early diagnosis. In the current study, we have used isobaric tag for relative and absolute quantitation (iTRAQ) labeling methodology coupled with high resolution mass spectrometry to identify and quantitate secreted proteins from a panel of head and neck carcinoma cell lines. In all, we identified 2,472 proteins, of which 225 proteins were secreted at higher or lower abundance in HNSCC-derived cell lines. Of these, 148 were present in higher abundance and 77 were present in lower abundance in the cancer-cell derived secretome. We detected a higher abundance of some previously known markers for HNSCC including insulin like growth factor binding protein 3, IGFBP3 (11-fold) and opioid growth factor receptor, OGFR (10-fold) demonstrating the validity of our approach. We also identified several novel secreted proteins in HNSCC including olfactomedin-4, OLFM4 (12-fold) and hepatocyte growth factor activator, HGFA (5-fold). IHC-based validation was conducted in HNSCC using tissue microarrays which revealed overexpression of IGFBP3 and OLFM4 in 70% and 75% of the tested cases, respectively. Our study illustrates quantitative proteomics of secretome as a robust approach for identification of potential HNSCC biomarkers. This article is part of a Special Issue entitled: An Updated Secretome. © 2013 Elsevier B.V.
cited By (since 1996)0
Cite this Research Publication
Related Research Publications
- SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome
- Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma
- Dysregulation of splicing proteins in head and neck squamous cell carcinoma.
- Chronic Exposure to Chewing Tobacco Selects for Overexpression of Stearoyl-CoA Desaturase in Normal Oral Keratinocytes
- Comment on "Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era" (Bar Ad V, Chalian A. Oral Oncol 2008;44:817-22)